Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRILACICLIB vs TRIMETHOBENZAMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRILACICLIB vs TRIMETHOBENZAMIDE: Safety Overview

Metric TRILACICLIB TRIMETHOBENZAMIDE
Total FAERS Reports 226 145
Deaths Reported 29 13
Death Rate 12.8% 9.0%
Hospitalizations 96 5
Average Patient Age 62.2 yrs 59.0 yrs
% Female Patients 43.9% 72.2%
FDA Approval Date Feb 12, 2021 Approved Prior to Jan 1, 1982
Manufacturer Pharmacosmos Therapeutics Inc. Heritage Pharmaceuticals Inc. d/b/a A...
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription